Overview
MOA
Impact
X
Procedure
Guidelines
Resources
Clinical Library
Reimbursement
Grants
Order Cysview
Overview
White vs. Blue Light
Patient Stories
Bladder Cancer Overview
X
Resources
Home
BLC™ with Cysview®
>
News
Health Care Professionals
>
Find a BLC with Cysview Center
X
Cysview LogoHamburger Menu Icon
Menu
Find a BLC with Cysview Center

Resources

Resources

Take Control of
Your Bladder Cancer

A cancer diagnosis comes with a range of emotions and uncertainties. It’s normal to feel overwhelmed, but it’s important to know you’re not alone. There are many resources that can help you through this journey, from understanding your disease to finding support in a caring community.

One of the greatest resources for patients and caregivers alike is BCAN (Bladder Cancer Advocacy Network). BCAN is a cooperative effort among bladder cancer survivors, their families and caregivers, and the medical community to improve public awareness of bladder cancer and increase research directed toward the diagnosis, treatment and cure of the disease.

Learn more about BCAN in the video above, from the BCAN website, or download the BCAN patient handbook (English or Español).

Additional Resources

Bladder Cancer: A Patient-Friendly Guide to Understanding Your Diagnosis and Treatment Options by David Pulver, Mark Schoenberg, MD, and Fran Pulver resulted from a unique collaboration between doctors and patients. The book combines expert medical information with a clear writing style that organizes and presents the information in the most patient friendly way. This book will help you be a proactive patient, have better conversations with your doctor, and become your own advocate in fighting bladder cancer. More information about this book is available at www.bladdercancerbook.org.

<  PREV  Bladder Cancer Overview
BACK TO TOP
NEXT  News  >

Prescribing Information

Cysview is an optical imaging agent indicated for use in the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy, or in patients undergoing surveillance cystoscopy for carcinoma of the bladder. Cysview is used with the KARL STORZ D-Light C Photodynamic Diagnostic (PDD) system to perform Blue Light Cystoscopy (BLCTM) as an adjunct to the white light cystoscopy.

Important Safety Information About Cysview® (hexaminolevulinate HCl)

Cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer. 

Anaphylactoid shock, hypersensitivity reactions, bladder pain, cystitis, and abnormal urinalysis have been reported after administration of Cysview. The most common adverse reactions seen in clinical trials were bladder spasm, dysuria, hematuria, and bladder pain. 

Cysview should not be used in patients with porphyria, gross hematuria, or with known hypersensitivity to hexaminolevulinate or any derivative of aminolevulinic acid. Cysview may fail to detect some malignant lesions. False-positive fluorescence may occur due to inflammation, cystoscopic trauma, scar tissue, previous bladder biopsy and recent BCG therapy or intravesical chemotherapy. No specific drug interaction studies have been performed. 

Safety and effectiveness have not been established in pediatric patients. There are no available data on Cysview use in pregnant women. Adequate reproductive and developmental toxicity studies in animals have not been performed. Systemic absorption following administration of Cysview is expected to be minimal. There are no data on the presence of hexaminolevulinate in human or animal milk, the effects on a breastfed infant, or the effects on milk production. The development and health benefits of breastfeeding should be considered along with the mother’s clinical need for Cysview and any potential adverse effects on the breastfed infant from Cysview or from the underlying maternal condition. 

Cysview is approved for use with the KARL STORZ D-Light C Photodynamic Diagnostic (PDD) system. For system set up and general information for the safe use of the PDD system, please refer to the KARL STORZ instruction manuals for each of the components. 

Prior to Cysview administration, read the Full Prescribing Information and follow the preparation and reconstitution instructions.

Photocure Logo